Comparing transcranial magnetic stimulation and esketamine treatment response trajectories in resistant depression.

J Affect Disord · 2026 · PMC13401942 · PMID 42259490

Europe PMC DOI

hedged sentence

0.0710

closest p · 1.4× alpha

0.0710

boldest claim

The sentences

a nonsignificant trendp = 0.071so close (0.05 < p ≤ 0.1)

Within the esketamine-treated group, no predictors reached significance; baseline PHQ-9 severity showed a nonsignificant trend toward higher odds of response (OR = 1.24, 95% CI 0.98–1.57, p = 0.071).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.